Hints for Doing a Thorough Board Member Review without Nitpicking or Wasting Time - PowerPoint PPT Presentation

1 / 36
About This Presentation
Title:

Hints for Doing a Thorough Board Member Review without Nitpicking or Wasting Time

Description:

Protecting our research subjects (volunteers), giving consideration to the ... Lapsed studies or those close to expiration should have first priority ... – PowerPoint PPT presentation

Number of Views:75
Avg rating:3.0/5.0
Slides: 37
Provided by: Pedi167
Category:

less

Transcript and Presenter's Notes

Title: Hints for Doing a Thorough Board Member Review without Nitpicking or Wasting Time


1
Hints for Doing a Thorough Board Member
Review(without Nitpicking or Wasting Time)
  • Maureen Brinkman, RN, MS, CCRC
  • SC, Pediatric Cardiology
  • U of U IRB Member 2003-2006

2
Its a 3-way balancing act between
  • Protecting our research subjects (volunteers),
    giving consideration to the Investigator fairly
    and finding time to do both EVERY month.

3
IRB Member Handbook by R. Amdur, MD (with my
modifications)
  • 1. Review your assignments as soon as you
  • get them.
  • 2. Get your questions answered
  • before the meeting.
  • 3. Consult with IRB staff, PI, SC and/or other
  • IRB members (esp. your co-reviewer) if
  • you have concerns.

4
Getting Started (my way)I tried to do this as
soon as I received my assignments.
  • First, each month read the minutes of the last
    meeting, especially sections that were about
    studies you reviewed or that were controversial.
  • Let your IRB coordinator know if there are
    errors and mention at the meeting that you
    submitted corrections.

5
Assess the Agenda
  • Lapsed studies or those close to expiration
    should have first priority
  • Continuing Reviews (aka Renewals)
  • Amendments
  • Tabled studies
  • New studies (as time permits)
  • Go through the whole list to look for any COIs
    (notify your IRB coordinator)
  • Studies in your specialty areas

6
Quick Check of Assignments
  • Number of assignments
  • Position on the Agenda
  • Primary vs. secondary reviewer
  • Expertise of the other reviewer?
  • Level of expertise outside my comfort zone
    (notify your IRB coordinator)
  • Overwhelmed? Dont wait until its too late
  • (notify your IRB coordinator right away)

7
Consent Process Requirements
  • Will the participant understand the consent form?
  • Will the prospective participant have enough time
    to think about whether or not to say yes?
  • Will the prospective participant be coerced into
    participating?
  • Who can give consent?
  • Only the participant?
  • A legal representative or guardian?

8
Consent Form Requirements
  • Background section
  • Does the form state that this is a research
    study?
  • What are the purposes of this research?

9
Consent Form Requirements
  • Procedures section
  • How long will the participant be in the study?
  • What procedures will be done?
  • Which procedures are experimental and which are
    standard of care?

10
Consent Form Requirements
  • Alternative Procedures section
  • Are there other courses treatments that might be
    advantageous to the participant?

11
Consent Form Requirements
  • Risks section
  • What are the risks of participating?
  • Medical risks of the procedures
  • Psychological risks of a positive test result,
  • answering sensitive questions, etc.
  • Confidentiality risks
  • Reproductive risks to a pregnant
  • woman and/or fetus.

12
Consent Form Requirements
  • Benefits section
  • What are the reasonable benefits of
    participating?
  • Sometimes there are no benefits to the
  • participant.
  • Compensation is not considered
  • a benefit.

13
Consent Form Requirements
  • Confidentiality and Authorization sections
  • How will the participants information be
    protected?
  • Who will have access to the participants PHI?
  • Authorization can be revoked
  • the participant will be
  • withdrawn from the study.

14
Consent Form Requirements
  • Person to Contact section
  • IRB statement
  • Who should the participant contact for
  • Questions, concerns, complains
  • If he/she is injured by being in the study
  • What if the participant does not feel comfortable
    contacting the PI?
  • The participant should know that
  • he/she can call the IRB.

15
Consent Form Requirements
  • Research-Related Injury section
  • Is medical treatment and compensation available
    if the participant is injured by being in the
    study?
  • Standard text has been developed
  • for this section.
  • Different for U of U, PCMC,
  • VA, Shriners.

16
Consent Form Requirements
Voluntary Participation section
  • Participation is voluntary.
  • The participant can say no or stop
    participation at any time.
  • Stopping will not affect the care and will cause
    penalty.

17
Consent Form Requirements
Costs Compensation section
  • Does the participant have to pay for the
    procedures?
  • Will someone else pay for the procedures?
  • Will the participant get paid to be in the study?

18
Consent Form Requirements
Other sections
  • Are there any unforeseeable risks?
  • Can the PI withdraw the participant from the
    study?
  • What if significant new information arises during
    the research study?
  • How many people will be enrolled in this study?

19
Consent Form Requirements
Possible Signatures
  • Participant
  • Parent(s)
  • Legally Authorized Representatives
  • Person Obtaining Consent
  • PI
  • Witness

20
Additional Considerations
  • Tissue Banking
  • Genetic Testing
  • Reportable Diseases
  • Placebo Use

21
Continuing Reviews
  • What to look for in the Renewal Application
  • 1. Study Status
  • - active
  • - closed to enrollment, but tx ongoing
  • - closed to enrollment, F/U only
  • - closed to enrollment, data analysis only
  • 2. Study Progress
  • - Description is thorough and honest
  • - Justification to continue is provided

22
Continuing Reviews
  • Enrollment Information
  • Numbers are reasonable or discrepancies are
    adequately explained.
  • Enrollment has not exceeded the approved or
    there is a request and justification for the
    increase.
  • Determine if there are unexpected events that may
    indicate a need for change to the protocol or
    consent.

23
Continuing Reviews
  • Points to remember (mine)
  • This study has already been reviewed by one or
    more previous Boards.
  • This study has already been reviewed by staff
    members in successive years.
  • Your main focus should be on any important
    changes to safety issues or IRB protection of
    human subjects guidelines since last review and
    on study progress.

24
Continuing Reviews
  • Points to consider before requesting a change
  • Did you notice something really important that
    was previously overlooked?
  • Would the change help protect the rights and/or
    welfare of the research subjects?
  • Do you feel certain that without the change, you
    would not feel comfortable approving the renewal?

25
Amendment Reviews
  • Review the amendment request and then verify that
    the changes have been made to the applicable
    documents.
  • Does the amendment significantly change the
    purpose, objectives, or design of the study?
  • If yes, the whole study may need to be
    re-evaluated.
  • If a new risk is identified
  • Has it already been addressed in the consent
    form?
  • Should current participants be re-consented or
    otherwise informed of the new risk?

26
New Study Application Reviews
  • The most important thing to remember is that
    these are the hardest and most time consuming
  • and
  • Most of the work has to be done before the full
    board meets.

27
New Study Applications (my way)
  • Scratch paper or note pad
  • Read the application first
  • If theres an Assent, read it first, then the PPF
  • Read the consent next
  • Read the Protocol summary
  • Take notes as you go, looking for discrepancies
    or things you dont understand
  • Now read the full protocol and the supporting
    documents
  • Re-read (scan) the consent

28
New Study Reviews (contd)
  • Study design
  • Study sponsor (Industry vs. Investigator
    Initiated vs. government sponsor)
  • Call around if you need to
  • Start the reviewer checklist
  • Watch for any points you might have
  • missed (the checklist may give you clues)
  • Make comments on the checklist (if you cant make
    at least one comment (good or bad), you probably
    dont really get it).

29
New Study Reviews (contd)
  • Remember your charge as a Board Member
  • (considering both ethics and the regulations)
  • by asking yourself these questions
  • If I qualified to be in this study, would I want
    to participate or let a member of my family
    participate?
  • Will the study population be able to understand
    the consent document?

30
New Study Reviews (contd)
  • If you answered no to any of those questions,
    you owe to yourself, the investigator, and the
    patient volunteers you care about to get some
    answers and clarifications and it should be done
    before the Board meeting.
  • Get more information from the IRB staff (they can
    contact the PI for you, too), the study
    investigator/coordinator, another reviewer, or
    the citizen rep on your panel.
  • If you still would answer one or more of those
    questions with a no, then the full board will
    need to discuss it once you make your
    recommendation to them at the meeting.

31
New Study Reviews (contd)
  • Remember
  • Read the consent document for consistency and
    readability. The pre-review by the IRB staff
    will usually catch any required elements that are
    missing.
  • Of course, we all like to see what is familiar
    and this makes it easier for us, but there is no
    requirement that the consent be done according to
    our IRB guidelines (only that all required
    elements are included will be discussed later).
    Most consents follow our guidelines, but try to
    be flexible for studies that use a different
    format for whatever reason.

32
Reconsidering a Previously Tabled Study
  • Does the new information provided by the
    Investigator answer the Boards concerns at the
    prior meeting?
  • If not, did the Board clearly articulate the
    essential information needed?
  • If either of the above is a no answer, would 1
    or 2 phone calls clear it up before the next
    meeting?
  • (You sure dont want to
  • have to table it again.)

33
Reconsidering a PreviouslyTabled Studies
  • If you still have major concerns that would
    prevent a recommendation to approve with changes
    specified, perhaps the Investigator should be
    invited to the meeting to answer questions.

34
Requesting Revisions
  • Make descriptive and specific revision requests.
  • If you dont have enough information to be
    specific, the study should be tabled.
  • If you dont have enough information, ask pointed
    questions so you get the right answer.
  • The IRB staff can help you re-word or re-phrase
    content in the consent form.
  • Write revisions in a way that you would want to
    receive them.

35
Presenting Your Review
  • Also remember
  • When you present your study to the Board, if you
    have written-up your brief description on the
    checklist well, you can just read it.
  • State your recommendation to the Board and try to
    present your rationale like a list of easy points
    to understand and discuss if necessary.
  • Use your citizen reps as needed they are a great
    resource!

36
The End! Any questions? Thanks!
Write a Comment
User Comments (0)
About PowerShow.com